Melinda Smith

2.0k total citations
18 papers, 813 citations indexed

About

Melinda Smith is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Melinda Smith has authored 18 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Melinda Smith's work include Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (7 papers) and Child and Adolescent Psychosocial and Emotional Development (3 papers). Melinda Smith is often cited by papers focused on Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (7 papers) and Child and Adolescent Psychosocial and Emotional Development (3 papers). Melinda Smith collaborates with scholars based in United States. Melinda Smith's co-authors include Zhi‐Ming Ding, David R. Powell, Brian Zambrowicz, Faika Mseeh, Arthur Sands, Duncan B. Clark, Christopher M. DaCosta, Angela L. Harris, Melanie K. Shadoan and Jennifer Greer and has published in prestigious journals such as American Journal of Psychiatry, Journal of Medicinal Chemistry and Clinical Psychology Review.

In The Last Decade

Melinda Smith

18 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melinda Smith United States 12 392 296 221 130 68 18 813
L.A.H. Borg Sweden 18 257 0.7× 449 1.5× 304 1.4× 48 0.4× 22 0.3× 32 1.2k
Matthew R. Nangle Australia 18 206 0.5× 95 0.3× 119 0.5× 54 0.4× 46 0.7× 41 909
Yukiko Kinoshita Japan 19 79 0.2× 176 0.6× 191 0.9× 144 1.1× 97 1.4× 51 952
Daniel B. Burnham United States 17 71 0.2× 197 0.7× 352 1.6× 270 2.1× 356 5.2× 28 1.2k
Joseph Aloi United States 20 600 1.5× 82 0.3× 218 1.0× 82 0.6× 60 0.9× 40 1.2k
Sara A. Paciga United States 12 52 0.1× 143 0.5× 349 1.6× 62 0.5× 81 1.2× 15 968
Alice Russell United Kingdom 13 37 0.1× 168 0.6× 209 0.9× 84 0.6× 38 0.6× 16 683
Daniel Griffiths-King United Kingdom 18 80 0.2× 63 0.2× 154 0.7× 71 0.5× 50 0.7× 44 1.2k
Liying Fu United States 17 68 0.2× 100 0.3× 231 1.0× 19 0.1× 48 0.7× 38 1.0k
Elena Y. Bryleva United States 12 28 0.1× 190 0.6× 290 1.3× 133 1.0× 34 0.5× 14 931

Countries citing papers authored by Melinda Smith

Since Specialization
Citations

This map shows the geographic impact of Melinda Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda Smith more than expected).

Fields of papers citing papers by Melinda Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda Smith. The network helps show where Melinda Smith may publish in the future.

Co-authorship network of co-authors of Melinda Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda Smith. A scholar is included among the top collaborators of Melinda Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda Smith. Melinda Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shi, Chunhua, Guojun Yang, Qing Shi, et al.. (2023). Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL. Leukemia. 37(10). 2006–2016. 6 indexed citations
2.
Hussain, Syed-Rehan A., et al.. (2019). Effect of cysteinyl leukotriene receptor 1 blockade on aeroallergen-induced nasal recruitment of CD49d expressing neutrophils. Annals of Allergy Asthma & Immunology. 123(5). 508–511.e1. 1 indexed citations
3.
Gammon, Seth T., Federica Pisaneschi, Madhavi Bandi, et al.. (2019). Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo. Cells. 8(12). 1487–1487. 20 indexed citations
4.
Powell, David R., Melinda Smith, Deon Doree, et al.. (2017). LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice. Journal of Pharmacology and Experimental Therapeutics. 362(1). 85–97. 25 indexed citations
5.
Goodwin, Nicole C., Zhi‐Ming Ding, Bryce A. Harrison, et al.. (2017). Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes. Journal of Medicinal Chemistry. 60(2). 710–721. 57 indexed citations
6.
Powell, D.R., Jason Gay, Melinda Smith, et al.. (2016). Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque. Diabetes Metabolic Syndrome and Obesity. 9. 185–185. 34 indexed citations
7.
Powell, David R., Melinda Smith, Deon Doree, et al.. (2015). LP‐925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2. Pharmacology Research & Perspectives. 3(2). e00129–e00129. 10 indexed citations
8.
Powell, David R., Christopher M. DaCosta, Melinda Smith, et al.. (2014). Effect of LX4211 on Glucose Homeostasis and Body Composition in Preclinical Models. Journal of Pharmacology and Experimental Therapeutics. 350(2). 232–242. 44 indexed citations
9.
Powell, David R., Melinda Smith, Jennifer Greer, et al.. (2013). LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose. Journal of Pharmacology and Experimental Therapeutics. 345(2). 250–259. 156 indexed citations
10.
Zambrowicz, Brian, Zhi‐Ming Ding, Ike Ogbaa, et al.. (2013). Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes. Clinical Therapeutics. 35(3). 273–285.e7. 65 indexed citations
11.
Powell, David R., Christopher M. DaCosta, Jason Gay, et al.. (2012). Improved glycemic control in mice lacking Sglt1 and Sglt2. American Journal of Physiology-Endocrinology and Metabolism. 304(2). E117–E130. 130 indexed citations
12.
Nangle, Douglas W., Jeffrey E. Hecker, Rachel L. Grover, & Melinda Smith. (2003). Perspective taking and adolescent sex offenders: From developmental theory to clinical practice. Cognitive and Behavioral Practice. 10(1). 73–84. 4 indexed citations
13.
Smith, Melinda & Jeffrey E. Hecker. (1997). Prevalence of panic disorder in post-myocardial infarction patients. 3(3). 197–204. 3 indexed citations
14.
Clark, Duncan B., et al.. (1995). Identifying anxiety disorders in adolescents hospitalized for alcohol abuse or dependence. Psychiatric Services. 46(6). 618–620. 63 indexed citations
15.
Clark, Duncan B., et al.. (1994). Anxiety disorders in adolescence: Characteristics, prevalence, and comorbidities. Clinical Psychology Review. 14(2). 113–137. 75 indexed citations
16.
Hirsch, Barry E., et al.. (1994). Panic in otolaryngology patients presenting with dizziness or hearing loss. American Journal of Psychiatry. 151(8). 1223–1225. 86 indexed citations
17.
Williams, Jon L., et al.. (1990). Defeat-induced hypoalgesia in the rat: Effects of conditioned odors, naltrexone, and extinction.. Journal of Experimental Psychology Animal Behavior Processes. 16(4). 345–357. 11 indexed citations
18.
Williams, Jon L., et al.. (1990). Defeat-induced hypoalgesia in the rat: Effects of conditioned odors, naltrexone, and extinction.. Journal of Experimental Psychology Animal Behavior Processes. 16(4). 345–357. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026